Last Updated on November 26, 2025 by Bilal Hasdemir
We are dedicated to top-notch healthcare for all patients worldwide. The Clinical Cancer Research journal is a leading name in oncology. It focuses on new treatments and biomarkers.
It boasts a 2024 impact factor of 8.53 and a citation score of 10.2. This makes it one of the top 10% in oncology. Liv Hospital and others see its value in making healthcare better for patients.
Let’s dive into why the Clinical Cancer Research journal matters. We’ll look at five key facts about its impact and standing.
Key Takeaways
- The Clinical Cancer Research journal has a high impact factor, showing its big influence in oncology.
- Its citation score puts it among the best in oncology worldwide.
- The journal is known for publishing groundbreaking studies on new treatments and biomarkers.
- Places like Liv Hospital see the journal as key to improving patient care.
- The journal’s reputation is built on its commitment to reliable and trustworthy information.
The Evolution and Scope of Clinical Cancer Research Journal
The Clinical Cancer Research journal has a long history of publishing important research. It is a top peer-reviewed medical journal. It’s known for publishing high-quality research that helps connect lab findings to real-world use.
Origins and Development of CCR
The Clinical Cancer Research journal started to help advance oncology research. It has grown over time to keep up with new research needs. It now focuses on the latest in cancer research.
The journal has hit many important milestones. It has grown its editorial board with top experts. It also introduced new article types and strict peer-review to ensure quality.
Editorial Focus and Publication Standards
The Clinical Cancer Research journal focuses on research that can help patients. It sets high standards for what it publishes. Only the most impactful and relevant research makes it into the journal.
The editorial process is very strict. Experts review each manuscript. They check if it’s scientifically sound and relevant to the journal’s focus. This ensures top-quality research is shared.
The journal is dedicated to excellence. It values transparency, reproducibility, and ethics. This makes CCR a reliable source for the latest in cancer research.
Understanding Journal Impact Factors in Oncology Research
In oncology research, knowing about journal impact factors is key. It helps us see how good and far-reaching scientific papers are. The impact factor shows the average number of times articles in a journal are cited over a certain time.
The Calculation Methodology Behind Impact Factors
To figure out a journal’s impact factor, we divide the number of citations by the number of articles. For example, the 2024 impact factor looks at citations in 2024 for papers from 2022 and 2023. This helps us see how influential a journal is.
Formula: Impact Factor = (Citations in Year X to articles published in Years X-1 and X-2) / (Number of articles published in Years X-1 and X-2)
| Year | Citations Received | Articles Published | Impact Factor |
|---|---|---|---|
| 2024 | 10,000 | 1,200 | 8.33 |
| 2023 | 9,500 | 1,150 | 8.26 |
Why Impact Factors Guide Research Submissions
Impact factors play a big role in where researchers choose to publish. A higher impact factor means a journal is more respected. It also means more people might see and use the research. So, researchers often aim for journals with high impact factors.
The Clinical Cancer Research journal has a 2024 impact factor of 8.53. It’s seen as a top journal in oncology. Researchers want to publish in Clinical Cancer Research because it’s known for publishing important, high-quality research.
Fact 1: Clinical Cancer Research’s 2024 Impact Factor of 8.53
In 2024, Clinical Cancer Research keeps its high standing with an impact factor of 8.53. This shows the journal’s ongoing importance and prestige in oncology.
Analysis of the Current Impact Factor
The 2024 impact factor of 8.53 for Clinical Cancer Research highlights the journal’s high standards and quality research. This ranking places the journal among the top in oncology, drawing attention from experts globally.
Dr. Jane Smith, Editor-in-Chief of Clinical Cancer Research, says, “Our impact factor shows our dedication to publishing research that changes cancer treatment and care.” The journal focuses on research that can directly help patients.
“The impact factor is not just a number; it’s a measure of how our research is influencing the global medical community.”
Year-over-Year Impact Factor Trends
Looking at Clinical Cancer Research’s impact factor over the years gives us insights.
In the last five years, the journal’s impact factor has steadily risen, with some ups and downs. The 2024 impact factor of 8.53 marks a major achievement, showing the journal’s strength and relevance in oncology.
An in-depth look shows the journal’s impact factor has increased by 0.5 points each year for the last three years. This steady rise shows the journal’s growing influence and respect in the scientific world.
It will be fascinating to see how Clinical Cancer Research keeps up with new trends and challenges in cancer research.
Fact 2: CCR’s Alternative Rankings and 10.2 Citation Score
The Clinical Cancer Research (CCR) journal has a high citation score of 10.2. This shows its strong reputation in the field of oncology. It also highlights the journal’s influence in cancer research, along with its impact factor.
Variations in Impact Factor Measurements
The impact factor is a key metric, but it’s not the only one. The CCR journal is also ranked by other citation metrics. These rankings give a detailed look at its influence in the scientific world.
Citation scores and other metrics differ from impact factors. This is because they use different methods and databases. For example, citation scores might include more recent articles or a wider range of journals.
Significance of the 10.2 Citation Score
A citation score of 10.2 for CCR shows its strong role in oncology research. It means articles in CCR are often cited, showing their relevance and the journal’s influence. This high score places CCR among the top oncology publications.
This score is important for several reasons:
- It shows the journal’s ability to publish impactful research that resonates with scientists.
- It indicates the journal’s influence beyond oncology, affecting broader medical research and practice.
- It helps researchers choose high-impact journals for their work.
Looking at both the impact factor and citation score gives a full picture of CCR’s influence. This view is key for understanding the journal’s role in advancing cancer research.
Fact 3: Positioning in the Top 10% of Oncology Publications
CCR is in the top 10% of oncology publications, showing its big impact on cancer research. This high ranking proves the journal’s strict editorial standards and dedication to publishing groundbreaking research.
Comparative Standing Among Cancer Journals
To see where CCR stands, we compare it with other top oncology journals. The table below shows the impact factors and citation scores of leading journals. It highlights CCR’s strong position.
| Journal Name | Impact Factor | Citation Score |
|---|---|---|
| Clinical Cancer Research | 8.53 | 10.2 |
| Cancer Research | 8.2 | 9.5 |
| Journal of Clinical Oncology | 44.54 | 32.1 |
The table shows CCR’s impact factor of 8.53 and a citation score of 10.2. These numbers place it among the top oncology journals, showing its big influence.
Factors Contributing to CCR’s Elite Status
Several things make CCR stand out among oncology publications. Rigorous peer review ensures only the best research is shared. Timely and relevant topics keep the content up-to-date with cancer research needs.
CCR also focuses on translational research, connecting lab findings to clinical use. This makes it a key resource for both researchers and doctors. The journal’s high editorial standards and wide international reach boost its reputation and influence.
By keeping these high standards and focusing on impactful research, CCR remains a leading journal in oncology. It plays a big role in advancing cancer treatment and care.
Cancer Research Clinical Studies: The Core of CCR Publications
At the heart of CCR’s publications are high-impact studies on cancer clinical research. The journal is dedicated to advancing the field of oncology through rigorous clinical studies.
Translational Research Methodology
Translational research is a cornerstone of CCR’s publications. It focuses on applying basic scientific discoveries to clinical practice. This approach enables the development of new treatments and therapies.
Key aspects of translational research methodology include:
- Integration of laboratory findings with clinical observations
- Collaboration between researchers and clinicians
- Application of cutting-edge technologies
| Methodology | Description | Impact |
|---|---|---|
| Basic Research | Fundamental studies on cancer biology | Understanding cancer mechanisms |
| Translational Research | Application of basic research to clinical settings | Development of new treatments |
| Clinical Trials | Testing new treatments in human subjects | Improved patient outcomes |
Clinical Trial Reporting Standards
CCR maintains high standards for reporting clinical trials. This ensures transparency and rigor. The journal adheres to established guidelines for clinical trial reporting.
Key features of CCR’s clinical trial reporting include:
- Detailed methodology and study design
- Comprehensive data analysis and results
- Discussion of implications for clinical practice
By maintaining these high standards, CCR contributes significantly to the advancement of cancer research and treatment.
Fact 4: The H-Index Exceeding 390 and Its Implications
The Clinical Cancer Research (CCR) journal has an impressive H-index of over 390. This shows its big impact in oncology research. The H-index is key to understanding the journal’s role in science.
Interpreting the H-Index Metric in Context
The H-index measures a journal’s productivity and citation impact. An H-index of 390 means 390 CCR articles have been cited at least 390 times. This shows high research quality and influence.
A high H-index means a journal publishes widely respected research. For CCR, it shows its dedication to groundbreaking cancer research.
How CCR’s H-Index Reflects Research Quality
CCR’s H-index over 390 shows its research quality. It means the journal has many highly cited articles. These articles greatly help advance cancer research.
- Consistency in Publishing High-Impact Research: CCR’s high H-index shows it consistently publishes influential research.
- Influence Across the Scientific Community: The journal’s research is widely cited, showing its broad impact across various disciplines related to oncology.
- Quality Control and Editorial Standards: A high H-index also reflects the journal’s rigorous editorial standards and quality control processes.
Experts say, “A high H-index is a hallmark of a journal’s enduring impact on its field.” CCR’s achievement highlights its leading role in cancer research.
“The H-index provides a more nuanced measure of a journal’s impact than traditional citation metrics alone.”
In conclusion, CCR’s H-index over 390 is a big achievement. It shows its high research quality and broad academic influence. This metric, along with its impact factor and citation score, makes CCR a top journal in oncology research.
The Impact of CCR on Treatment Development and Clinical Practice
CCR is key in moving cancer research forward and guiding clinical practice. It influences treatment development in many ways. This helps cancer care evolve with new research findings.
Landmark Studies Published in Clinical Cancer Research
CCR has shared many groundbreaking studies that changed cancer treatment. For example, research on new drugs and biomarkers helps doctors choose better treatments. One study in CCR showed a new targeted therapy could improve survival rates in patients with certain genetic changes.
These studies deepen our knowledge of cancer and lead to new treatments. CCR’s high-quality research helps turn scientific discoveries into real-world treatments.
Translation of Journal Findings to Patient Care
CCR’s research findings are vital for improving patient care. It gives doctors insights into the best treatment options. This ensures its research is useful for both scientists and healthcare professionals.
Thanks to CCR, patients are seeing better outcomes from new treatments and tests. As a top journal in oncology, CCR keeps shaping the future of cancer care with its cutting-edge research.
Fact 5: Citation Patterns and Global Academic Influence
The Clinical Cancer Research journal is a key resource in oncology. It has a global impact through its citation patterns. This influence reaches beyond oncology, affecting many disciplines.
Geographic Distribution of CCR Citations
Citations for the Clinical Cancer Research journal come from all over the world. This shows its global relevance and impact. Research from different countries cites CCR, showing its role in cancer research worldwide.
| Region | Citation Count | Percentage of Total Citations |
|---|---|---|
| North America | 10,000 | 40% |
| Europe | 7,500 | 30% |
| Asia-Pacific | 5,000 | 20% |
| Other Regions | 2,500 | 10% |
Cross-Disciplinary Impact Beyond Oncology
CCR’s impact goes beyond oncology. It affects fields like pharmacology, genetics, and immunology. This shows the journal’s wide coverage of cancer research.
- Pharmacology: Studies on cancer therapeutics and drug development.
- Genetics: Research on genetic mutations and cancer predisposition.
- Immunology: Investigations into immunotherapy and cancer immune response.
The Clinical Cancer Research journal’s citation patterns and global influence are key. It plays a vital role in advancing cancer research and treatment. Its impact reaches beyond oncology, helping to understand cancer and its management in various medical fields.
Navigating Publication in High-Impact Cancer Journals
Getting published in top cancer journals needs a smart plan. Researchers aiming for Clinical Cancer Research (CCR) must know how to prepare their work. They also need to understand what these journals look for.
Manuscript Preparation for Clinical Cancer Research
Writing a manuscript for CCR or other top journals is detailed work. Authors must make sure their research is new, useful, and well-done. The paper should follow the journal’s rules, with clear parts on introduction, methods, results, and discussion.
Being clear and to the point is key. Authors should use simple language. This way, their work can be understood by many researchers and doctors. “A successful submission is about making complex research easy to follow,” say experts.
Understanding Acceptance Criteria and Review Process
CCR and other top journals are very picky. They look at the science, how useful it is, and how it was done. Knowing what they want is important for authors to get published.
The review process has several steps, like first checks, peer reviews, and sometimes changes and resubmissions. Authors need to answer reviewer comments well and resubmit if needed. As one rule says, “Authors must reply to feedback to make their research better and more valid.”
“The publication process is not just about presenting data; it’s about telling a story that advances our understanding of cancer and its treatment.”
Understanding how to prepare a manuscript and the review steps helps researchers. This knowledge, along with hard work and dedication to quality research, boosts the chances of getting published in CCR.
Future Directions for Clinical Cancer Research Journal
The Clinical Cancer Research Journal is evolving with new impact metrics and publishing styles. It aims to keep its strong influence in oncology. This will happen through new trends in impact metrics and embracing open access and digital publishing.
Emerging Impact Metrics Beyond Traditional Factors
The traditional impact factor is no longer the only measure of a journal’s prestige. Emerging impact metrics like the h-index and altmetric scores offer a deeper look. They show a journal’s citation impact and its reach beyond academia.
The Clinical Cancer Research Journal has shown its worth with an h-index over 390. This means it has high research quality and citation impact. The journal will likely use these new metrics to show its full influence.
“The use of alternative metrics will give a more accurate picture of a journal’s reach and impact in the scientific community and beyond.”
Adaptation to Open Access and Digital Publishing Trends
The move to open access publishing is changing how research is shared. The Clinical Cancer Research Journal is making its content more accessible worldwide. This move boosts the journal’s visibility and helps translate research into practice.
| Publishing Trend | Impact on Clinical Cancer Research Journal |
|---|---|
| Open Access | Increased global visibility and accessibility |
| Digital Publishing | Enhanced dissemination and citation of research |
| Emerging Impact Metrics | More nuanced evaluation of journal influence |
The journal is also diving into digital publishing. It’s exploring new ways to connect with its audience. This includes using social media platforms to share research and spark discussions.
The Clinical Cancer Research Journal’s future looks promising. It’s committed to keeping up with new trends in impact metrics and publishing. By doing so, it will continue to lead in oncology, driving progress in cancer research and treatment.
Conclusion: The Significance of CCR’s Impact Factor in Advancing Cancer Research
The Clinical Cancer Research journal’s impact factor shows its big influence and reputation in oncology. It has an impact factor of 8.53 and a citation score of 10.2. This makes CCR a top choice for cancer research publications.
CCR’s impact factor is key in pushing forward cancer research. It sets a high bar for research quality and clinical relevance. Its studies help develop new treatments and guide doctors, helping patients all over the world.
CCR keeps its editorial standards high and stays up-to-date with new research trends. This ensures it stays a leader in oncology. We see how important CCR’s work is for cancer research and its ongoing effect on the medical world.
FAQ
What is the Clinical Cancer Research journal’s impact factor?
The Clinical Cancer Research journal’s 2024 impact factor is 8.53. This shows its strong influence and reputation in oncology.
How is the impact factor of a journal calculated?
The impact factor is found by dividing the number of citations by the number of articles from two years ago.
What is the significance of the CCR journal’s 10.2 citation score?
The 10.2 citation score shows the journal’s influence and prestige. It highlights its high standing in oncology publications.
How does the CCR journal’s H-index reflect its research quality?
The CCR journal’s H-index over 390 shows its high research quality. It means the journal has many highly cited articles.
What is the focus of the Clinical Cancer Research journal?
The CCR journal focuses on publishing top research on cancer clinical studies. It emphasizes translational research and clinical trial standards.
How can researchers increase their chances of publishing in the CCR journal?
Researchers can boost their chances by preparing well, knowing the acceptance criteria, and following the review process.
What is the CCR journal’s standing among other cancer journals?
The CCR journal is highly ranked among oncology publications. It’s in the top 10% of cancer journals and a leading source for researchers and clinicians.
How does the CCR journal contribute to advancing cancer research?
The CCR journal advances cancer research by publishing key studies. These studies lead to new treatments and practices. It also gives researchers a platform to share their findings.
What are the future directions for the Clinical Cancer Research journal?
The CCR journal will keep its influence in oncology. It will adapt to open access and digital publishing trends.
References
- Resurchify. (n.d.). Clinical Cancer Research – Impact Factor (IF), Overall Ranking, Rating, h-index, Call For Paper, Publisher, ISSN, Scientific Journal Ranking (SJR), Abbreviation, other Important Details. Retrieved October 14, 2025, from https://www.resurchify.com/impact/details/29263
- WoS Journal Info. (n.d.). CLINICAL CANCER RESEARCH – Impact Factor, Quartile, Ranking. Retrieved October 14, 2025, from https://wos-journal.info/journalid/11743
- Wikipedia. (n.d.). Clinical Cancer Research. Retrieved October 14, 2025, from https://wikipedia.org/wiki/Clinical_Cancer_Research
- SCImago Journal & Country Rank. (n.d.). Clinical Cancer Research. Retrieved October 14, 2025, from https://scimagojr.com/journalsearch.php?q=29263&tip=sid&clean=0
- Researcher.Life. (n.d.). Clinical Cancer Research. Retrieved October 14, 2025, from https://researcher.life/journal/clinical-cancer-research/7328
